[HTML][HTML] Inhaled pulmonary vasodilators: a narrative review

K Liu, H Wang, SJ Yu, GW Tu, Z Luo - Annals of Translational …, 2021 - ncbi.nlm.nih.gov
Pulmonary hypertension (PH) is a severe disease that affects people of all ages. It can occur
as an idiopathic disorder at birth or as part of a variety of cardiovascular and pulmonary …

[HTML][HTML] Right ventricular failure: current strategies and future development

M Monteagudo-Vela, A Tindale… - Frontiers in …, 2023 - frontiersin.org
Right heart failure can be defined as a clinical syndrome consistent of signs and symptoms
of heart failure resulting from right ventricular dysfunction. Function is normally altered due to …

Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients

H Torbic, PM Szumita, KE Anger, P Nuccio… - Journal of Critical …, 2013 - Elsevier
Purpose The purpose of this is to compare efficacy, safety, and cost outcomes in patients
who have received either inhaled epoprostenol (iEPO) or inhaled nitric oxide (iNO) for …

A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome

AL Dzierba, EE Abel, MS Buckley… - … : The Journal of Human …, 2014 - Wiley Online Library
Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are conditions
associated with an estimated mortality of 40–50%. The use of inhaled vasodilators can help …

[HTML][HTML] Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome

D Nayyar, HSJ Man, J Granton, LB Lilly… - American Journal of …, 2015 - Elsevier
The hepatopulmonary syndrome (HPS) is defined as the triad of liver disease,
intrapulmonary vascular dilatation, and abnormal gas exchange, and is found in 10–32% of …

Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension

A Keshavarz, H Kadry, A Alobaida… - Expert opinion on drug …, 2020 - Taylor & Francis
Introduction: Pulmonary arterial hypertension (PAH) is a progressive disease characterized
by remodeling of small pulmonary arteries leading to increased pulmonary arterial pressure …

A comparison of inhaled nitric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery

K McGinn, M Reichert - Annals of Pharmacotherapy, 2016 - journals.sagepub.com
Background: Direct comparisons of inhaled nitric oxide (iNO) to inhaled epoprostenol (iEPO)
in patients with acute pulmonary hypertension (PHT) following cardiac surgery are lacking …

Inhaled pulmonary vasodilator therapy for management of right ventricular dysfunction after left ventricular assist device placement and cardiac transplantation

LA Sabato, DM Salerno, JD Moretz… - … : The Journal of …, 2017 - Wiley Online Library
Right ventricular failure (RVF) after cardiac transplant (CTX) or implantation of a continuous‐
flow left ventricular assist device (CF‐LVAD) is associated with significant postoperative …

2015 年先天性心脏病相关性肺动脉高压诊治中国专家共识

高伟, 顾红, 胡大一, 华益民, 黄奕高, 李奋… - 中国介入心脏病学 …, 2015 - cqvip.com
2015年先天性心脏病相关性肺动脉高压诊治中国专家共识-[维普官方网站]-www.cqvip.com-维普
网  我的维普 购物车 充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线 …

Pulmonary hypertension in the intensive care unit

JC Jentzer, MA Mathier - Journal of intensive care medicine, 2016 - journals.sagepub.com
Pulmonary hypertension occurs as the result of disease processes increasing pressure
within the pulmonary circulation, eventually leading to right ventricular failure. Patients may …